Stocks
Alnylam Pharmaceuticals (ALNY) P/S US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| P/S | ? | 57.3 | 30.3 | 23.8 | 27.9 | 13.1 | 10.3 | ||
| Changes by years, y/y, % | -42% | -47% | -22% | +17% | -53% | -33.1% | |||
Alnylam Pharmaceuticals. P/S
Alnylam Pharmaceuticals. P/S, changes, %
Alnylam Pharmaceuticals (ALNY) P/S US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| P/S | ? | 12.9 | 13.2 | 9.41 | 13.1 | 17.6 | 10.3 | |
| Changes by years, y/y, % | -49% | -53% | -57% | -31% | +36% | |||
| Changes by quarters, q/q, % | -33% | +2% | -28% | +40% | +34% | |||
